Virbac has completed the acquisition of Globion, an Indian poultry vaccine specialist, increasing its stake to 100% to expand its market presence in the veterinary pharmaceutical sector.

Target Information

Virbac has completed the acquisition of minority shares in Globion, an Indian specialist in poultry vaccines, effectively transferring the company's ownership from a 74% majority stake to a full 100%. This strategic move comes after an initial acquisition on November 1, 2023, marking a significant step in expanding Virbac's presence in the veterinary pharmaceutical market.

Established in 2005 as a joint venture between Suguna Group, a prominent Indian poultry conglomerate, and Lohmann Animal Health, a German leader in poultry vaccine development, Globion has cultivated extensive expertise in designing, manufacturing, and marketing both live and inactivated vaccines that combat a wide range of avian pathogens. The company's headquarters in Hyderabad supports approximately 120 employees across industrial and research and development operations, generating around €12 million in revenue in 2023.

Industry Overview

The poultry vaccine industry in India is experiencing significant growth, driven by increasing poultry farming practices and heightened awareness regarding animal health. With a burgeoning demand